Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F16%3AN0000065" target="_blank" >RIV/00023728:_____/16:N0000065 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1093/rheumatology/kew179" target="_blank" >https://doi.org/10.1093/rheumatology/kew179</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/rheumatology/kew179" target="_blank" >10.1093/rheumatology/kew179</a>
Alternative languages
Result language
angličtina
Original language name
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
Original language description
Secondary analysis of study Go-More, which has performed analysis of set of baseline factors to predict remission or LDA after 1 months treatment with golimumab.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30227 - Geriatrics and gerontology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Rheumatology
ISSN
1462-0324
e-ISSN
—
Volume of the periodical
55
Issue of the periodical within the volume
8
Country of publishing house
GB - UNITED KINGDOM
Number of pages
11
Pages from-to
1466-1476
UT code for WoS article
000383847200017
EID of the result in the Scopus database
—